Entasis Therapeutics Holdings Inc. Aktie
Aktien
A2N4R0
US2936141033
ETTX
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01.05.15 |
Ruben Tommasi
CTO | Chief Tech/Sci/R&D Officer | 58 | 01.05.15 |
David Altarac
CTO | Chief Tech/Sci/R&D Officer | 63 | 04.11.19 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
David Hastings
BRD | Director/Board Member | 62 | 01.04.18 |
Director/Board Member | 58 | 01.08.17 | |
Heather Behanna
BRD | Director/Board Member | 49 | 01.08.17 |
% 1. Jan. | Kap. | |
---|---|---|
-0.49% | 103 Mrd. | |
+3.31% | 96.73 Mrd. | |
+1.66% | 21.31 Mrd. | |
-16.16% | 21.21 Mrd. | |
-6.82% | 18.79 Mrd. | |
-41.41% | 16.37 Mrd. | |
-22.87% | 13.68 Mrd. | |
+6.32% | 13.44 Mrd. | |
+21.46% | 10.98 Mrd. |